STOCKSCOPE

Mount Ridley Mines (ASX: MRD) Achieves 96% Vanadium Recovery. Is Selectro Becoming Bigger Than Its Scandium Resource?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:5d ago
Mount Ridley Mines (ASX: MRD) Achieves 96% Vanadium Recovery. Is Selectro Becoming Bigger Than Its Scandium Resource?

A reported 96% vanadium recovery from titanomagnetite has added another potential application to Mount Ridley Mines Limited's (ASX: MRD) proprietary Selectro processing technology. With earlier laboratory tests also demonstrating promising scandium, rare earth, aluminium and gallium recoveries, the company's commercial opportunity may extend beyond its substantial mineral resource portfolio.

The bigger question is whether Selectro can become an economically competitive processing technology across multiple industrial feedstocks, rather than remain a collection of promising laboratory results.

Key numbers

  • 96%: Vanadium recovery reported from titanomagnetite in the 3 November 2026 announcement.
  • 946.1 million tonnes: Inferred scandium mineral resource at Grass Patch, grading 50.1 parts per million.
  • 91.8%: Scandium recovery achieved using Selectro, alongside approximately 84% average heavy rare earth recovery.
  • 95%: Gallium recovery reported from a selected bauxite composite in October testing.
  • $3.065 million: Cash at 30 September 2026, with quarterly operating cash outflow of $792,000.

The latest development

Mount Ridley's 3 November announcement reported 96% vanadium recovery from titanomagnetite using its Selectro technology.

The result introduces another potential industrial application for a process previously tested on scandium and rare earth-bearing material from Grass Patch, as well as third-party bauxite.

Vanadium is used in steel alloys and certain energy-storage technologies, making its recovery from titanomagnetite commercially relevant if processing can be demonstrated at competitive costs.

However, a laboratory recovery percentage does not establish commercial viability.

The key unanswered questions include reagent consumption, vanadium concentrations in the feedstock, product purity, separation efficiency and the cost of processing larger material volumes.

Without demonstrated economics, the latest result represents technical progress rather than evidence of future revenue.

What stands out to us

Mount Ridley's developing advantage is the potential adaptability of Selectro chemistry.

September testing achieved 91.8% scandium recovery while using approximately half the reagent dose of earlier trials. Subsequent bauxite testing delivered 91.9% aluminium recovery and 95% gallium recovery from selected material.

These results suggest the technology may have applications beyond a single deposit.

Nevertheless, performance across different feedstocks remains an important commercial uncertainty. Optimising recovery of one metal can compromise another, as demonstrated when gallium recovery fell to 41.5% during the improved scandium test.

The company's financial position also warrants attention.

At 30 September, Mount Ridley held $3.065 million in cash following a $2 million placement. Its $792,000 quarterly operating cash outflow implied approximately 3.9 quarters of funding at that historical expenditure rate.

Larger-scale testing and demonstration plant development could increase cash requirements substantially.

What the company is doing now

Mount Ridley is pursuing two interconnected opportunities: developing its Grass Patch Critical Minerals Project near Esperance and commercialising Selectro across alternative industrial materials.

Grass Patch contains an Inferred scandium resource of 946.1 million tonnes, representing approximately 47,357 tonnes of contained scandium metal.

The company is advancing flotation testing, resource re-assaying, processing optimisation and preliminary demonstration plant planning.

It has also lodged provisional patent applications covering Selectro technology and industrial processing applications.

These activities could support future licensing or processing opportunities, although no associated commercial revenue has been established.

Insight: Could Selectro Become More Valuable Than Grass Patch?

We think Mount Ridley's most interesting asset may ultimately be its processing technology rather than the sheer size of its scandium resource. The latest vanadium result strengthens the case for broader technical applications, potentially reducing reliance on a single mineral development project. However, laboratory recovery rates alone cannot justify substantial commercial valuations. Processing costs, feedstock variability, metal separation and funding requirements remain unresolved. Our assessment is cautiously positive on Selectro's technical potential but conservative on its financial value until independent scale-up results demonstrate repeatable, commercially competitive economics.

What happens next?

The most important milestones are further Selectro optimisation, bulk and pilot-scale testing, and clearer demonstration plant capital and operating cost estimates.

Additional Grass Patch resource work could strengthen the company's mineral development prospects, although the resource remains entirely Inferred.

For existing shareholders, the decisive development will be evidence that Selectro can deliver commercially attractive metal recovery at scale.

Mount Ridley has now demonstrated promising laboratory recoveries across several metals. Proving those recoveries can generate sustainable economic value is the challenge that matters most.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...